Matthew Breen :: PhD :: C.Biol :: FRSB ::
Professor of Genomics and the Oscar J. Fletcher Distinguished Professor of Comparative Oncology Genetics

  • Gregory Tawa, John Braisted, Dave Gerhold, Gurmit Grewal, Christina Mazcko, Matthew Breen, Sitta Sittampalam, Amy Leblanc (2021). Proteo-genomics of cancer in canines and humans reveals molecular signatures for drug discovery and blood-based biopsy. Science Translational Medicine 17(9):e1009450 PMID: 34570764
  • Peart, Claire; Williams, Christina ; Pophaly, Saurabh; Neely, Benjamin; Gulland, Frances; Adams, David; Ng, Bee; Cheng, William; Goebel, Michael; Fedrigo, Olivier; Haase, Bettina; Mountcastle, Jacquelyn; Fungtammasan, Arkarachai; Formenti, Giulio; Collins, Joanna; Wood, Jonathan; Sims, Ying; Torrance, James; Tracey, Alan; Howe, Kerstin; Rhie, Arang; Hoffman, Joe; Johnson, Jeremy; Jarvis, Erich; Breen, Matthew*; Wolf, Jochen* (2021). Hi-C scaffolded short and long-read genome assemblies of the California sea lion are broadly consistent for syntenic inference across 45 million years of evolution. Molecular Ecology Resources, June 2021 (DOI: 10.1111/1755-0998.13443) *Co-senior authors PMID: 34097816  OPEN ACCESS
  • Jong Hyuk Kim, Kate Megquier, Rachael Thomas, Aaron L Sarver, Jung Min Song, Yoon Tae Kim, Nuojin Cheng, Ashley J Schulte, Michael A Linden, Paari Murugan, LeAnn Oseth, Colleen L Forster, Ingegerd Elvers, Ross Swofford, Jason Turner-Maier, Elinor K Karlsson, Matthew Breen, Kerstin Lindblad-Toh, Jaime F Modiano (2021). Genomically complex human angiosarcoma and canine hemangiosarcoma establish convergent angiogenic transcriptional programs driven by novel gene fusions. Molecular Cancer Research 19(5):847-861.  PMID: 33649193   PMCID: PMC8137578
  • Paul Rossman, Tanja S Zabka, A. Audrey Ruple, Dietrich Tuerck, Jose A. Ramos-Vara, Liling Liu, Rodrigo Mohallem, Mark Merchant, Jackeline Franco, Christopher M. Fulkerson, Ketaki P Bhide, Matthew Breen, Uma K Aryal, Elaine R Murray, Noel Dybdal, Sagar M Utturkar, Lindsey M Fourez, Alexander W. Enstrom, Deepika Dhawan, and Deborah W Knapp (2021). Phase I / II trial of vemurafenib in dogs with naturally-occurring, BRAF-mutated urothelial carcinoma. Molecular Cancer Therapeutics 20(11):2177–2188.  PMID: 34433660